JULIE ESQUINALDO: Open Payments
NPI 1154375046 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,941 in 88 payments from 18 companies in 2025. Trend: 2023 $1,227 · 2024 $1,452 · 2025 $1,941
Food & beverage: $1,861Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $294 |
| PFIZER INC. | 15 | $232 |
| Botanix SB Inc | 10 | $206 |
| Galderma Laboratories, L.P. | 12 | $199 |
| Organon LLC | 4 | $166 |
| Lilly USA, LLC | 3 | $146 |
| Janssen Biotech, Inc. | 6 | $139 |
| Regeneron Healthcare Solutions, Inc. | 7 | $135 |
| UCB, Inc. | 4 | $110 |
| Amgen Inc. | 4 | $83 |
Products named: SOFDRA, NEMLUVIO, SKYRIZI, EBGLYSS, TREMFYA, Bimzelx, DUPIXENT, LITFULO.
Industry payments across FL — which companies pay providers there.
